This study will evaluate whether treatment with Naproxen 500 mg twice daily is superior to
placebo for the improvement of leg pain in patients with sciatica. Half of patients will
receive Naproxen while the other half will receive placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Ostfold Hospital Trust
Collaborators:
Helse Stavanger HF Oslo University Hospital Sykehuset Telemark Vestre Viken Hospital Trust